Skip to Content

1,025 Results Found

  • Review
  • Open Access
84 Citations
16,667 Views
18 Pages

18 July 2020

Over the past decades, adoptive transfer of T cells has revolutionized cancer immunotherapy. In particular, T-cell receptor (TCR) engineering of T cells has marked important milestones in developing more precise and personalized cancer immunotherapie...

(This article belongs to the Special Issue TCR Gene Therapy: Challenges, Opportunities and Future Directions)
  • Review
  • Open Access
2 Citations
6,366 Views
20 Pages

Exploiting TCR Repertoire Analysis to Select Therapeutic TCRs for Cancer Immunotherapy

  • Ursule M. Demaël,
  • Thunchanok Rirkkrai,
  • Fatma Zehra Okus,
  • Andreas Tiffeau-Mayer and
  • Hans J. Stauss

7 August 2025

Over the past decade, numerous innovative immunotherapy strategies have transformed the treatment of cancer and improved the survival of patients unresponsive to conventional chemotherapy and radiation therapy. Immune checkpoint inhibition approaches...

(This article belongs to the Special Issue Recent Advances in Novel Cell and Gene Therapies for the Treatment of Immune Diseases)
  • Review
  • Open Access
15 Citations
6,921 Views
14 Pages

25 November 2022

The interaction of the T-cell receptor (TCR) with a peptide in the major histocompatibility complex (pMHC) plays a central role in the adaptive immunity of higher chordates. Due to the high specificity and sensitivity of this process, the immune syst...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
10 Citations
4,125 Views
17 Pages

Cross-TCR Antagonism Revealed by Optogenetically Tuning the Half-Life of the TCR Ligand Binding

  • Omid Sascha Yousefi,
  • Matias Ruggieri,
  • Vincent Idstein,
  • Kai Uwe von Prillwitz and ,
  • Laurenz A. Herr,
  • Julia Chalupsky,
  • Maja Köhn,
  • Wilfried Weber,
  • Jens Timmer and
  • Wolfgang W. A. Schamel
  • + 5 authors+ 0 author

Activation of T cells by agonistic peptide-MHC can be inhibited by antagonistic ones. However, the exact mechanism remains elusive. We used Jurkat cells expressing two different TCRs and tested whether stimulation of the endogenous TCR by agonistic a...

(This article belongs to the Special Issue The Many Facets of the Regulation of TCR Signaling)
  • Review
  • Open Access
106 Citations
14,105 Views
14 Pages

Human γδ TCR Repertoires in Health and Disease

  • Alina Suzann Fichtner,
  • Sarina Ravens and
  • Immo Prinz

26 March 2020

The T cell receptor (TCR) repertoires of γδ T cells are very different to those of αβ T cells. While the theoretical TCR repertoire diversity of γδ T cells is estimated to exceed the diversity of αβ T cel...

(This article belongs to the Special Issue Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran)
  • Review
  • Open Access
149 Citations
18,431 Views
26 Pages

TCR Recognition of Peptide–MHC-I: Rule Makers and Breakers

  • Christopher Szeto,
  • Christian A. Lobos,
  • Andrea T. Nguyen and
  • Stephanie Gras

T cells are a critical part of the adaptive immune system that are able to distinguish between healthy and unhealthy cells. Upon recognition of protein fragments (peptides), activated T cells will contribute to the immune response and help clear infe...

(This article belongs to the Special Issue Recent Advances in T Cell Immunity)
  • Feature Paper
  • Review
  • Open Access
52 Citations
24,309 Views
20 Pages

Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer

  • Yimo Sun,
  • Fenge Li,
  • Heather Sonnemann,
  • Kyle R. Jackson and ,
  • Amjad H. Talukder,
  • Arjun S. Katailiha and
  • Gregory Lizee
  • + 2 authors+ 0 author

10 September 2021

Engineered T cell receptor T (TCR-T) cell therapy has facilitated the generation of increasingly reliable tumor antigen-specific adaptable cellular products for the treatment of human cancer. TCR-T cell therapies were initially focused on targeting s...

(This article belongs to the Special Issue Targetable Cellular Components of the Immune Microenvironment in Solid Tumors)
  • Review
  • Open Access
54 Citations
8,974 Views
21 Pages

Breaking Bottlenecks for the TCR Therapy of Cancer

  • Lena Gaissmaier,
  • Mariam Elshiaty and
  • Petros Christopoulos

14 September 2020

Immune checkpoint inhibitors have redefined the treatment of cancer, but their efficacy depends critically on the presence of sufficient tumor-specific lymphocytes, and cellular immunotherapies develop rapidly to fill this gap. The paucity of suitabl...

(This article belongs to the Special Issue TCR Gene Therapy: Challenges, Opportunities and Future Directions)
  • Article
  • Open Access
5 Citations
3,328 Views
13 Pages

n-3 Polyunsaturated Fatty Acids Impede the TCR Mobility and the TCR–pMHC Interaction of Anti-Viral CD8+ T Cells

  • Younghyun Lim,
  • Seyoung Kim,
  • Sehoon Kim,
  • Dong-In Kim and ,
  • Kyung Won Kang,
  • So-Hee Hong,
  • Sang-Myeong Lee,
  • Hye Ran Koh and
  • Young-Jin Seo
  • + 4 authors+ 0 author

12 June 2020

The immune-suppressive effects of omega-3 (n-3) polyunsaturated fatty acids (PUFAs) on T cells have been observed via multiple in vitro and in vivo models. However, the precise mechanism that causes these effects is still undefined. In this study, we...

(This article belongs to the Special Issue Viral Evasion or Suppression of Host Immunity)
  • Article
  • Open Access
16 Citations
6,204 Views
13 Pages

Cooperative Interaction of Nck and Lck Orchestrates Optimal TCR Signaling

  • Frederike A. Hartl,
  • Jatuporn Ngoenkam,
  • Esmeralda Beck-Garcia,
  • Liz Cerqueira and ,
  • Piyamaporn Wipa,
  • Pussadee Paensuwan,
  • Prapat Suriyaphol,
  • Pankaj Mishra,
  • Burkhart Schraven and
  • Susana Minguet
  • + 8 authors+ 3 authors

7 April 2021

The T cell antigen receptor (TCR) is expressed on T cells, which orchestrate adaptive immune responses. It is composed of the ligand-binding clonotypic TCRαβ heterodimer and the non-covalently bound invariant signal-transducing CD3 complex. Among the...

(This article belongs to the Special Issue Molecular Mechanisms of Early T Cell Signaling)
  • Article
  • Open Access
13 Citations
8,277 Views
19 Pages

Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules

  • Janine Dilchert,
  • Martin Hofmann,
  • Felix Unverdorben,
  • Roland Kontermann and
  • Sebastian Bunk

Bispecific T cell receptor (TCR)-based molecules capable of redirecting and activating T cells towards tumor cells represent a novel and promising class of biotherapeutics for the treatment of cancer. Usage of TCRs allows for targeting of intracellul...

  • Review
  • Open Access
42 Citations
18,136 Views
21 Pages

Targeting the MHC Ligandome by Use of TCR-Like Antibodies

  • Lene Støkken Høydahl,
  • Rahel Frick,
  • Inger Sandlie and
  • Geir Åge Løset

Monoclonal antibodies (mAbs) are valuable as research reagents, in diagnosis and in therapy. Their high specificity, the ease in production, favorable biophysical properties and the opportunity to engineer different properties make mAbs a versatile c...

  • Article
  • Open Access
1 Citations
1,285 Views
21 Pages

Novel Two-Chamber Method for High-Precision TCR Determination of Current Shunts—Part I

  • Petar Mostarac,
  • Roman Malarić,
  • Hrvoje Hegeduš and
  • Alan Šala

19 May 2025

The temperature coefficient of resistance (TCR) plays a crucial role in ensuring the functional accuracy of systems. This article examines the determination of TCR for precision current shunts and presents a novel two-chamber method. The method uses...

(This article belongs to the Special Issue Feature Papers in Electronic Sensors 2025)
  • Article
  • Open Access
1 Citations
1,456 Views
14 Pages

Peripheral Blood TCR Clonotype Diversity as a Biomarker for Colorectal Cancer

  • Gaochen Zhu,
  • Tao Chen,
  • Chen Ma,
  • Kai Liu and ,
  • Bihui Huang and
  • Guan Yang
  • + 1 author+ 0 author

There exists an urgent need to improve colorectal cancer (CRC) diagnosis due to limitations in current diagnostic approaches. Systematic characterization of the human T cell receptor (TCR) repertoire, coupled with advanced computational methods, prov...

(This article belongs to the Special Issue Computer Vision and Machine Learning in Medical Applications, 2nd Edition)
  • Review
  • Open Access
19 Citations
4,725 Views
11 Pages

TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma

  • Sophia B. Strobel,
  • Devayani Machiraju and
  • Jessica C. Hassel

26 February 2022

Metastatic uveal melanoma (mUM) is one of the most rapidly progressing tumors, with a bad prognosis and no standard-of-care treatment. Immune checkpoint inhibitors have revolutionized cancer therapy and improved overall survival in patients with meta...

(This article belongs to the Special Issue Advances in the Treatment of Metastatic Uveal Melanoma)
  • Review
  • Open Access
88 Citations
17,317 Views
34 Pages

18 June 2020

T cell receptor (TCR)-based adoptive T cell therapies (ACT) hold great promise for the treatment of cancer, as TCRs can cover a broad range of target antigens. Here we summarize basic, translational and clinical results that provide insight into the...

(This article belongs to the Special Issue TCR Gene Therapy: Challenges, Opportunities and Future Directions)
  • Review
  • Open Access
20 Citations
7,232 Views
20 Pages

1 June 2020

Natural adaptive immunity co-evolved with pathogens over millions of years, and adoptive transfer of non-engineered T cells to fight infections or cancer so far exhibits an exceptionally safe and functional therapeutic profile in clinical trials. How...

(This article belongs to the Special Issue TCR Gene Therapy: Challenges, Opportunities and Future Directions)
  • Article
  • Open Access
5 Citations
5,261 Views
15 Pages

Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing

  • Saleh Alrhmoun,
  • Marina Fisher,
  • Julia Lopatnikova,
  • Olga Perik-Zavodskaia and ,
  • Marina Volynets,
  • Roman Perik-Zavodskii,
  • Julia Shevchenko,
  • Kirill Nazarov,
  • Julia Philippova and
  • Sergey Sennikov
  • + 8 authors+ 3 authors

30 November 2024

Background: Adoptive cell therapy is the most promising approach for battling cancer, with T cell receptor-engineered T (TCR-T) cell therapy emerging as the most viable option for treating solid tumors. Current techniques for preparing TCR-T cell the...

(This article belongs to the Topic Novel Discoveries in Oncology)
  • Review
  • Open Access
71 Citations
10,018 Views
21 Pages

Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?

  • Andrea Aran,
  • Laia Garrigós,
  • Giuseppe Curigliano,
  • Javier Cortés and
  • Mercè Martí

31 March 2022

T cells play a vital role in the anti-tumoural response, and the presence of tumour-infiltrating lymphocytes has shown to be directly correlated with a good prognosis in several cancer types. Nevertheless, some patients presenting tumour-infiltrating...

(This article belongs to the Collection The Biomarkers for the Diagnosis and Prognosis in Cancer)
  • Article
  • Open Access
995 Views
13 Pages

TCR Repertoire Analysis Unveils the Link Between Kawasaki Disease and Viral Infection

  • Zhimi Geng,
  • Wei Zhou,
  • Zhihao Fang,
  • Yihua Jin and ,
  • Guoqiang Qi,
  • Lin Zhao,
  • Chunhong Xie,
  • Yujia Wang and
  • Fangqi Gong
  • + 4 authors+ 0 author

Background: Kawasaki disease (KD) is a systemic vasculitis of unknown origin, though recent evidence implicates viral pathogens in its pathogenesis. Given the central role of T cell receptors (TCRs) in antigen recognition and immune response, this st...

(This article belongs to the Section Molecular and Translational Medicine)
  • Article
  • Open Access
16 Citations
5,059 Views
13 Pages

A Cysteine Residue within the Kinase Domain of Zap70 Regulates Lck Activity and Proximal TCR Signaling

  • Annika Schultz,
  • Marvin Schnurra,
  • Ali El-Bizri,
  • Nadine M. Woessner and ,
  • Sara Hartmann,
  • Roland Hartig,
  • Susana Minguet,
  • Burkhart Schraven and
  • Luca Simeoni
  • + 4 authors+ 0 author

1 September 2022

Alterations in both the expression and function of the non-receptor tyrosine kinase Zap70 are associated with numerous human diseases including immunodeficiency, autoimmunity, and leukemia. Zap70 propagates the TCR signal by phosphorylating two impor...

(This article belongs to the Section Cell Signaling)
  • Article
  • Open Access
8 Citations
3,824 Views
20 Pages

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4

  • Alaa Alsalloum,
  • Julia Shevchenko,
  • Marina Fisher,
  • Julia Philippova and ,
  • Roman Perik-Zavodskii,
  • Olga Perik-Zavodskaia,
  • Saleh Alrhmoun,
  • Julia Lopatnikova,
  • Kurilin Vasily and
  • Sergey Sennikov
  • + 11 authors+ 6 authors

13 October 2023

TCR-like chimeric antigen receptor (CAR-T) cell therapy has emerged as a game-changing strategy in cancer immunotherapy, offering a broad spectrum of potential antigen targets, particularly in solid tumors containing intracellular antigens. In this s...

(This article belongs to the Special Issue Advances in Targeted Immunotherapy in Cancers)
  • Review
  • Open Access
10 Citations
11,136 Views
12 Pages

TCR Transgenic Mice: A Valuable Tool for Studying Viral Immunopathogenesis Mechanisms

  • Yong-Bin Cho,
  • In-Gu Lee,
  • Yong-Hyun Joo,
  • So-Hee Hong and
  • Young-Jin Seo

18 December 2020

Viral infectious diseases are a significant burden on public health and the global economy, and new viral threats emerge continuously. Since CD4+ and CD8+ T cell responses are essential to eliminating viruses, it is important to understand the underl...

(This article belongs to the Special Issue Transgenic Mice in Human Diseases: Insights from Molecular Research)
  • Review
  • Open Access
476 Views
26 Pages

4 October 2026

Soluble T-cell receptor (TCR)-based biologics (protein-based) are an emerging class of immunotherapeutic agents that recognize antigenic peptides presented by the human leukocyte antigen (HLA) on the surface of target cells. Furthermore, they simulta...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
9 Citations
5,074 Views
17 Pages

TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors

  • Alaa Alsalloum,
  • Saleh Alrhmoun,
  • Julia Shevchenko,
  • Marina Fisher and ,
  • Julia Philippova,
  • Roman Perik-Zavodskii,
  • Olga Perik-Zavodskaia,
  • Julia Lopatnikova,
  • Vasily Kurilin and
  • Sergey Sennikov
  • + 9 authors+ 4 authors

Adoptive T-cell therapies tailored for the treatment of solid tumors encounter intricate challenges, necessitating the meticulous selection of specific target antigens and the engineering of highly specific T-cell receptors (TCRs). This study delves...

(This article belongs to the Special Issue Advances in Therapeutic Strategies and Precision Medicine in Solid Tumors and Metastasis)
  • Article
  • Open Access
2 Citations
3,074 Views
9 Pages

Erythroid Differentiation Regulator 1 Strengthens TCR Signaling by Enhancing PLCγ1 Signal Transduction Pathway

  • Myun Soo Kim,
  • Dongmin Park,
  • Sora Lee,
  • Sunyoung Park and ,
  • Kyung Eun Kim,
  • Tae Sung Kim,
  • Hyun Jeong Park and
  • Daeho Cho
  • + 3 authors+ 0 author

Erythroid differentiation regulator 1 (Erdr1) has previously been reported to control thymocyte selection via TCR signal regulation, but the effect of Erdr1 as a TCR signaling modulator was not studied in peripheral T cells. In this report, it was de...

(This article belongs to the Special Issue The Many Facets of the Regulation of TCR Signaling)
  • Article
  • Open Access
13 Citations
7,100 Views
12 Pages

mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma

  • Marina Tusup,
  • Severin Läuchli,
  • Natalia Teresa Jarzebska,
  • Lars E. French and ,
  • Yun-Tsan Chang,
  • Maya Vonow-Eisenring,
  • Andreas Su,
  • Thomas M. Kündig,
  • Emmanuella Guenova and
  • Steve Pascolo
  • + 5 authors+ 0 author

Efficient vaccination can be achieved by injections of in vitro transcribed mRNA (ivt mRNA) coding for antigens. This vaccine format is particularly versatile and allows the production of individualised vaccines conferring, T-cell immunity against sp...

(This article belongs to the Special Issue Delivery Systems of Plasmid DNA and Messenger RNA for Advanced Therapies)
  • Article
  • Open Access
11 Citations
3,764 Views
14 Pages

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer

  • Julie Lecuelle,
  • Romain Boidot,
  • Hugo Mananet,
  • Valentin Derangère and ,
  • Juliette Albuisson,
  • Vincent Goussot,
  • Laurent Arnould,
  • Zoé Tharin,
  • Isabelle Ray Coquard and
  • Jean-David Fumet
  • + 7 authors+ 2 authors

31 August 2021

Purpose: Immune infiltration is a prognostic factor in high-grade serous ovarian carcinoma (HGSC) but immunotherapy efficacy is disappointing. Genomic instability is now used to guide the therapeutic value of PARP inhibitors. We aimed to investigate...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
3 Citations
4,278 Views
16 Pages

TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy

  • Qingqing Lin,
  • Fenglan Liu,
  • Yipeng Ma,
  • Yanwei Li and ,
  • Tong Lin,
  • Xiaochun Chen,
  • Jinling Zhang,
  • Heng Sun,
  • Zhi Wang and
  • Mingjun Wang
  • + 8 authors+ 3 authors

25 August 2025

Background: T-cell receptor (TCR)-engineered T-cell therapy (TCR-T) has become a promising anticancer therapy. Recognition of tumor cells by TCR-T cells requires matched human leukocyte antigen (HLA) alleles and tumor antigens, which seriously limits...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Review
  • Open Access
3 Citations
2,772 Views
20 Pages

28 November 2025

Type 1 diabetes mellitus (T1DM) is an autoimmune disease caused by the destruction of insulin-producing pancreatic β-cells by autoreactive T cells. Current treatments, including insulin replacement therapy and various immunotherapies, often modu...

(This article belongs to the Special Issue Autoimmune Diseases: From Pathogenesis to Treatment and Prognostic Markers)
  • Review
  • Open Access
9 Citations
6,696 Views
21 Pages

8 September 2021

Despite the advent of novel therapies, acute myeloid leukemia (AML) remains associated with a grim prognosis. This is exemplified by 5-year overall survival rates not exceeding 30%. Even with frontline high-intensity chemotherapy regimens and allogen...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
2 Citations
3,538 Views
12 Pages

The Activity and Stability of p56Lck and TCR Signaling Do Not Depend on the Co-Chaperone Cdc37

  • Sarah Kowallik,
  • Andreas Kritikos,
  • Matthias Kästle,
  • Christoph Thurm and ,
  • Burkhart Schraven and
  • Luca Simeoni
  • + 1 author+ 0 author

24 December 2020

Lymphocyte-specific protein tyrosine kinase (Lck) is a pivotal tyrosine kinase involved in T cell receptor (TCR) signaling. Because of its importance, the activity of Lck is regulated at different levels including phosphorylation of tyrosine residues...

(This article belongs to the Special Issue The Many Facets of the Regulation of TCR Signaling)
  • Article
  • Open Access
10 Citations
3,446 Views
19 Pages

The Tyrosine Phosphatase Activity of PTPN22 Is Involved in T Cell Development via the Regulation of TCR Expression

  • Bin Bai,
  • Tong Li,
  • Jiahui Zhao,
  • Yanjiao Zhao and ,
  • Xiaonan Zhang,
  • Tao Wang,
  • Na Zhang,
  • Xipeng Wang,
  • Xinlei Ba and
  • Bing Wang
  • + 7 authors+ 2 authors

25 September 2023

The protein tyrosine phosphatase PTPN22 inhibits T cell activation by dephosphorylating some essential proteins in the T cell receptor (TCR)-mediated signaling pathway, such as the lymphocyte-specific protein tyrosine kinase (Lck), Src family tyrosin...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
8 Citations
4,771 Views
20 Pages

A Novel, LAT/Lck Double Deficient T Cell Subline J.CaM1.7 for Combined Analysis of Early TCR Signaling

  • Inmaculada Vico-Barranco,
  • Mikel M. Arbulo-Echevarria,
  • Isabel Serrano-García,
  • Alba Pérez-Linaza and ,
  • José M. Miranda-Sayago,
  • Arkadiusz Miazek,
  • Isaac Narbona-Sánchez and
  • Enrique Aguado
  • + 3 authors+ 0 author

6 February 2021

Intracellular signaling through the T cell receptor (TCR) is essential for T cell development and function. Proper TCR signaling requires the sequential activities of Lck and ZAP-70 kinases, which result in the phosphorylation of tyrosine residues lo...

(This article belongs to the Special Issue Molecular Mechanisms of Early T Cell Signaling)
  • Article
  • Open Access
6 Citations
3,416 Views
15 Pages

Y192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection

  • Matthias Kästle,
  • Camilla Merten,
  • Roland Hartig,
  • Carlos Plaza-Sirvent and ,
  • Ingo Schmitz,
  • Ursula Bommhardt,
  • Burkhart Schraven and
  • Luca Simeoni
  • + 3 authors+ 0 author

Signaling via the TCR, which is initiated by the Src-family tyrosine kinase Lck, is crucial for the determination of cell fates in the thymus. Because of its pivotal role, ablation of Lck results in a profound block of T-cell development. Here, we sh...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
28 Citations
5,648 Views
15 Pages

Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR

  • Christopher Szeto,
  • Andrea T. Nguyen,
  • Christian A. Lobos,
  • Demetra S. M. Chatzileontiadou and ,
  • Dhilshan Jayasinghe,
  • Emma J. Grant,
  • Alan Riboldi-Tunnicliffe,
  • Corey Smith and
  • Stephanie Gras
  • + 4 authors+ 0 author

3 October 2021

The data currently available on how the immune system recognises the SARS-CoV-2 virus is growing rapidly. While there are structures of some SARS-CoV-2 proteins in complex with antibodies, which helps us understand how the immune system is able to re...

(This article belongs to the Collection Cellular Immunology and COVID-19)
  • Review
  • Open Access
25 Citations
15,179 Views
12 Pages

11 June 2025

Chimeric antigen receptor (CAR)-T and T-cell receptor (TCR)-engineered T-cell (TCR-T) therapies have revolutionized the treatment of hematological malignancies; however, their application to solid tumors remains a formidable challenge. The immunosupp...

(This article belongs to the Collection Advances in Clinical Trials: Outcome, Innovations, Challenges, and Ethical Practice in Cancer Research 2025–2026)
  • Article
  • Open Access
983 Views
19 Pages

Novel Two-Chamber Method for High-Precision TCR Determination of Current Shunts—Part II

  • Petar Mostarac,
  • Roman Malarić,
  • Hrvoje Hegeduš and
  • Alan Šala

22 October 2025

This paper presents the experimental implementation and validation of the two-chamber method presented in Part I for the high-precision determination of the temperature coefficient of resistance (TCR) of current shunts. The two-chamber approach enabl...

(This article belongs to the Special Issue Feature Papers in Electronic Sensors 2025)
  • Review
  • Open Access
25 Citations
8,648 Views
36 Pages

25 January 2022

Despite the substantial improvement of therapeutic approaches, multiple myeloma (MM) remains mostly incurable. However, immunotherapeutic and especially T cell-based approaches pioneered the therapeutic landscape for relapsed and refractory disease r...

(This article belongs to the Collection Multiple Myeloma and Cellular Therapies)
  • Review
  • Open Access
36 Citations
9,895 Views
12 Pages

19 August 2021

Chimeric antigen receptor and T-cell receptor (CAR-T/TCR-T) cellular immunotherapies have shown remarkable success in the treatment of some refractory B-cell malignancies, with potential to provide durable clinical response for other types of cancer....

(This article belongs to the Special Issue Cancer in Human Health and Healthcare)
  • Article
  • Open Access
7 Citations
2,095 Views
13 Pages

This study investigated the influence of microstructure on the performance of Ag inkjet-printed, resistive temperature detectors (RTDs) fabricated using particle-free inks based on a silver nitrate (AgNO3) precursor and ethylene glycol as the ink sol...

(This article belongs to the Special Issue Microstructured Sensors: From Design to Application)
  • Article
  • Open Access
1 Citations
3,616 Views
16 Pages

Single-Cell TCR Sequencing Uncovers Remodeling of the Immune Repertoire After a Short-Term Gluten-Free Diet in Pediatric Celiac Disease

  • Rafael Martín-Masot,
  • Marta Herrador-López,
  • Víctor Manuel Navas-López,
  • Francisco David Carmona and ,
  • Sara González-Muñoz,
  • Elena López-Isac,
  • Teresa Nestares and
  • Lara Bossini-Castillo
  • + 3 authors+ 0 author

13 September 2025

Celiac disease (CD) is a chronic autoimmune disorder triggered by gluten in genetically susceptible individuals. While gluten-free diet (GFD) remains the primary treatment, the molecular mechanisms underlying immune reconstitution remain poorly under...

(This article belongs to the Collection Feature Paper Collection in Molecular Endocrinology and Metabolism)
  • Article
  • Open Access
4 Citations
3,878 Views
14 Pages

Expression of Non-T Cell Activation Linker (NTAL) in Jurkat Cells Negatively Regulates TCR Signaling: Potential Role in Rheumatoid Arthritis

  • Isaac Narbona-Sánchez,
  • Alba Pérez-Linaza,
  • Isabel Serrano-García,
  • Inmaculada Vico-Barranco and ,
  • Luis M. Fernández-Aguilar,
  • José L. Poveda-Díaz,
  • María J. Sánchez del Pino,
  • Fermín Medina-Varo,
  • Mikel M. Arbulo-Echevarria and
  • Enrique Aguado
  • + 5 authors+ 0 author

26 February 2023

T lymphocytes are key players in adaptive immune responses through the recognition of peptide antigens through the T Cell Receptor (TCR). After TCR engagement, a signaling cascade is activated, leading to T cell activation, proliferation, and differe...

(This article belongs to the Special Issue Cellular Signalling Transduction)
  • Article
  • Open Access
9 Citations
4,080 Views
13 Pages

20 February 2020

T cells play an essential role in the immune response against the human respiratory syncytial virus (hRSV). It has been described that both CD4+ and CD8+ T cells can contribute to the clearance of the virus during an infection. However, for some indi...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
2 Citations
4,225 Views
20 Pages

Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies

  • Maja Bürdek,
  • Petra U. Prinz,
  • Kathrin Mutze,
  • Stefanie Tippmer and ,
  • Christiane Geiger,
  • Giulia Longinotti and
  • Dolores J. Schendel
  • + 2 authors+ 0 author

13 January 2025

Background/Objectives: MDG1011 is an autologous TCR-T therapy developed as a treatment option for patients with myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and multiple myeloma (MM). It is specific fo...

(This article belongs to the Special Issue New Insights of Hematology in Cancer)
  • Article
  • Open Access
9 Citations
5,501 Views
16 Pages

Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell Lymphoma

  • Beatrice Belmonte,
  • Valeria Cancila,
  • Alessandro Gulino,
  • Mohsen Navari and ,
  • Walter Arancio,
  • Paolo Macor,
  • Andrea Balduit,
  • Sara Capolla,
  • Gaia Morello and
  • Alessandro Mangogna
  • + 14 authors+ 9 authors

12 June 2021

Due to the high expression of P-selectin glycoprotein ligand-1 (PSGL-1) in lymphoproliferative disorders and in multiple myeloma, it has been considered as a potential target for humoral immunotherapy, as well as an immune checkpoint inhibitor in T-c...

(This article belongs to the Special Issue Molecular Pathogenesis and Management of Anaplastic Large Cell Lymphoma)
  • Article
  • Open Access
27 Citations
5,369 Views
15 Pages

MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo

  • Sebastian J. Schober,
  • Melanie Thiede,
  • Hendrik Gassmann,
  • Carolin Prexler and ,
  • Busheng Xue,
  • David Schirmer,
  • Dirk Wohlleber,
  • Stefanie Stein,
  • Thomas G. P. Grünewald and
  • Uwe Thiel
  • + 8 authors+ 3 authors

29 June 2020

In this study we report the functional comparison of T cell receptor (TCR)-engineered major histocompatibility complex (MHC) class I-restricted CD4+ versus CD8+ T cells targeting a peptide from six transmembrane epithelial antigen of the prostate 1 (...

(This article belongs to the Special Issue TCR Gene Therapy: Challenges, Opportunities and Future Directions)
  • Article
  • Open Access
1 Citations
2,740 Views
18 Pages

First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms

  • Simone Thomas,
  • Martin Wermke,
  • Vladan Vučinić,
  • Eva Wagner-Drouet and ,
  • Andreas Mackensen,
  • Robert Zeiser,
  • Gesine Bug,
  • Michael Schmitt,
  • Wolfgang Herr and
  • Dolores J. Schendel
  • + 13 authors+ 8 authors

11 September 2025

Background/objectives: MDG1011 is a Preferentially Expressed Antigen in Melanoma (PRAME)-specific autologous T cell receptor (TCR) T cell therapy for HLA-A*02:01-positive patients. Data from the first-in-human (FIH) clinical trial, CD-TCR-001, are re...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Review
  • Open Access
23 Citations
16,757 Views
24 Pages

Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”

  • Karin Teppert,
  • Xueting Wang,
  • Kathleen Anders,
  • César Evaristo and ,
  • Dominik Lock and
  • Annette Künkele
  • + 1 author+ 0 author

23 November 2022

T cell-based immunotherapy has demonstrated great therapeutic potential in recent decades, on the one hand, by using tumor-infiltrating lymphocytes (TILs) and, on the other hand, by engineering T cells to obtain anti-tumor specificities through the i...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
47 Citations
8,412 Views
18 Pages

Early Pregnancy Human Decidua is Enriched with Activated, Fully Differentiated and Pro-Inflammatory Gamma/Delta T Cells with Diverse TCR Repertoires

  • Antonia Terzieva,
  • Violeta Dimitrova,
  • Lyubomir Djerov,
  • Petya Dimitrova and ,
  • Silvina Zapryanova,
  • Iana Hristova,
  • Ivaylo Vangelov and
  • Tanya Dimova
  • + 3 authors+ 0 author

Pregnancy is a state where high and stage-dependent plasticity of the maternal immune system is necessary in order to equilibrate between immunosuppression of harmful responses towards the fetus and ability to fight infections. TCR γδ cel...

(This article belongs to the Special Issue Reproductive Immunology: Cellular and Molecular Biology)

of 21